Charles Stimpson
Family Medicine · Shelbyville, TNNPI 1780654285
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $648 and has fallen 93.9% since, to $40 in 2022.
Across 90 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$204
- Johnson & Johnson$198
- Merck$140
- AstraZeneca$137
- Novo Nordisk$119
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$116
- plus $573 from 12 others
What the payments were for
- Food & beverage$1,487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 11 | $204 |
| Johnson & Johnson | 13 | $198 |
| Merck | 9 | $140 |
| AstraZeneca | 10 | $137 |
| Novo Nordisk | 7 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $116 |
| Amarin Pharma, Inc. | 7 | $115 |
| Boehringer Ingelheim | 6 | $105 |
| Esperion Therapeutics, Inc. | 3 | $70 |
| AbbVie(2 entities) | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| GSK | 3 | $39 |
| Amgen | 1 | $24 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Pfizer | 1 | $23 |
| Mylan Specialty L.p. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
How this compares
$1,487 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 27 | $507 |
| Atorvastatin Calcium | 50 | $506 |
| Omeprazole | 55 | $411 |
| Valsartan | 15 | $392 |
| Irbesartan | 12 | $233 |
| Metformin Hcl ErMetformin Hcl | 16 | $148 |
| ClopidogrelClopidogrel Bisulfate | 27 | $148 |
| Levothyroxine Sodium | 15 | $139 |
| Citalopram HbrCitalopram Hydrobromide | 33 | $137 |
| Losartan Potassium | 14 | $133 |
| Metoprolol Succinate | 11 | $130 |
| Amlodipine Besylate | 18 | $58 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Shelbyville
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
- Ellen ClelandChattanooga$38K
- Meredith SchweitzerAntioch$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.